comparemela.com

Latest Breaking News On - Josep llovet - Page 1 : comparemela.com

Durvalumab Plus Bevacizumab Improves TACE Outcomes in HCC

A new study showed improved progression-free survival when systemic therapy is added to TACE for HCC. Overall survival outcomes are pending.

United-states
Italy
New-york
American
Josep-llovet
Riccardo-lencioni
University-of-pisa
American-society-of-clinical-oncology
American-society
Clinical-oncology
Mount-sinai-hospital
Hepatocellular-carcinoma-hcc-liver-cancer-of-the

Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trial

Numerical advantages in OS, PFS fall short of statistical significance

Barcelona
Comunidad-autonoma-de-cataluna
Spain
New-york
United-states
Hong-kong
American
Landon-chan
Josep-llovet
Stephen-chan
Icahn-school-of-medicine-at-mount-sinai
Tisch-cancer-institute

Shrinking Liver Cancer Tumors Before Transplant Yields Excellent Outcomes, Mount Sinai Researchers Report

Shrinking Liver Cancer Tumors Before Transplant Yields Excellent Outcomes, Mount Sinai Researchers Report
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Milan
Lombardia
Italy
United-states
Josep-llovet
Parissa-tabrizian
Icahn-school-of-medicine-at-mount-sinai
Mount-sinai
Associate-professor
Icahn-school
Liver-cancer-program
Mount-sinai-health

Liver cancer appears to be resistant to immunotherapy in patients with liver condition

Liver cancer appears to be resistant to immunotherapy in patients with liver condition
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Westchester
Long-island
Josep-llovet
Amaia-lujambio
Thomas-marron
Philipp-haber
Health-system
Twitter
Tisch-cancer-institute
Youtube

vimarsana © 2020. All Rights Reserved.